CotrimoxazoleMaculopapular rash, fixed drug eruption and type 1 hypersensitivity reaction: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1861卷 / 1期

关键词：

D O I：

10.1007/s40278-021-97901-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：101 / 101

相关论文

共 50 条

[1] ParacetamolMaculopapular rash, fixed drug eruption and DRESS syndrome: 5 case reports
Reactions Weekly, 2018, 1696 (1) : 299 - 299
[2] Enfortumab-vedotin/pembrolizumabCutaneous drug eruption and hypersensitivity reaction: 3 case reports
Reactions Weekly, 2021, 1869 (1) : 148 - 148
[3] AntibacterialsRecurrent fixed drug eruption: 3 case reports
Reactions Weekly, 2018, 1733 (1) : 48 - 48
[4] InfliximabAllergic reaction and delayed type hypersensitivity reaction: 3 case reports
Reactions Weekly, 2020, 1817 (1) : 174 - 174
[5] Multiple drugsDrug hypersensitivity reaction manifesting as exanthematous morbilliform drug eruption: 7 case reports
Reactions Weekly, 2020, 1808 (1) : 202 - 202
[6] OmalizumabAnaphylactic reaction and type I hypersensitivity: 3 case reports
Reactions Weekly, 2022, 1911 (1) : 339 - 339
[7] DupilumabWorsening of conjunctivitis, fixed drug eruption and impaired consciousness: 3 case reports
Reactions Weekly, 2023, 1941 (1) : 180 - 180
[8] Mefenamic acid/paracetamolGeneralized bullous fixed drug eruption: 3 case reports
Reactions Weekly, 2015, 1571 (1) : 163 - 163
[9] AllopurinolStevens Johnson syndrome, drug hypersensitivity and rash: 16 case reports
Reactions Weekly, 2012, 1384 (1) : 7 - 7
[10] Multiple drugsGeneralised bullous fixed drug eruption and contraindicated drug administered: 3 case reports
Reactions Weekly, 2022, 1913 (1) : 304 - 304

← 1 2 3 4 5 →